Dr. Domenick J Sorresso M.D.

Recommended Articles

• These Conditions Can Cause Dyspnea

  OverviewDyspnea is the clinical term for shortness of breath or breathlessness experienced by both healthy individuals and patients with respiratory or cardiovascular diseases. It can also be a temporary condition that quickly resolves on its own or a symptom of a more serious health condition. A...

• What Causes Asthma?

  Asthma is a kind of disease that is characterized by affecting the airways/outlets that carry air to and from the lungs. People who suffer from this chronic condition (long-lasting or recurrent) are said to be asthmatic. This disease comes like a bolt from the blue - a three-pronged attack on the...

• COPD: Know the Signs and Symptoms – Pink Puffers and Blue Bloaters

  COPD is a chronic lung condition that makes it difficult for you to breathe. Know about the signs and symptoms of chronic obstructive pulmonary disease (COPD), Blue Bloater and Pink puffer do not develop until the later stages of this disease. COPD is a term used to describe progressive lung...

• Can Pleurisy Destroy My Lungs?

  What is pleurisy?Pleurisy is the inflammation of the thin pleural membranes that line the lungs.What happens in pleurisy?A thin membrane called the pleura lines your lungs. The pleura are double-layered membranes that line your lungs as well as the inner aspect of the chest wall. Between these...

• What Is Pneumocystis Carinii Pneumonia?

  Pneumocystis carinii pneumonia (PCP) is a very serious disease, which is characterized by a fluid buildup and inflammation in the lungs. This lung infection is caused by the fungus Pneumocystis jiroveci. It is an opportunistic disease that usually infects immunosuppressed individuals, especially...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...